ArticleAmerican journal of nuclear medicine and molecular imaging2012
Current neuroimaging techniques in Alzheimer's disease and applications in animal models.
Article in American journal of nuclear medicine and molecular imaging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Investigating the Potential Impact of Air Pollution on Alzheimer's Disease and the Utility of Multidimensional Imaging for Early Detection.ACS omega · 2024Review
- Fully automated radiosynthesis of [American journal of nuclear medicine and molecular imaging · 2024Article
- Automated radiosynthesis of [American journal of nuclear medicine and molecular imaging · 2024Article
- Automated radiosynthesis of [American journal of nuclear medicine and molecular imaging · 2023Article
- Identification of marker genes in Alzheimer's disease using a machine-learning model.Bioinformation · 2021Article
- Automated production of [American journal of nuclear medicine and molecular imaging · 2021Article
- Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.Journal of Alzheimer's disease : JAD · 2017Article
- Insight into the Molecular Imaging of Alzheimer's Disease.International journal of biomedical imaging · 2016Review
- Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America · 2015Article
- Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics.Small (Weinheim an der Bergstrasse, Germany) · 2014Review
- Quantum dot-based nanoprobes for in vivo targeted imaging.Current molecular medicine · 2013Review
- Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease.Journal of the American Chemical Society · 2013Article
- Pharmacokinetic issues of imaging with nanoparticles: focusing on carbon nanotubes and quantum dots.Molecular imaging and biology · 2013Review
- Hemodynamic and neuropathological analysis in rats with aluminum trichloride-induced Alzheimer's disease.PloS one · 2013Article
- A review of neuroimaging biomarkers of Alzheimer's disease.Neurology Asia · 2013Article
- Multimodality imaging of RNA interference.Current medicinal chemistry · 2013Review
- Molecular imaging strategies for in vivo tracking of microRNAs: a comprehensive review.Current medicinal chemistry · 2013Review
- Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.Molecular pharmaceutics · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With Alzheimer's disease (AD) quickly becoming the most costly disease to society, and with no disease-modifying treatment currently, prevention and early detection have become key points in AD research. Important features within this research focus on understanding disease pathology, as well as finding biomarkers that can act as early indicators and trackers of disease progression or potential treatment. With the advances in neuroimaging technology and the development of new imaging techniques, the search for cheap, noninvasive, sensitive biomarkers becomes more accessible. Modern neuroimaging techniques are able to cover most aspects of disease pathology, including visualization of senile plaques and neurofibrillary tangles, cortical atrophy, neuronal loss, vascular damage, and changes in brain biochemistry. These methods can provide complementary information, resulting in an overall picture of AD. Additionally, applying neuroimaging to animal models of AD could bring about greater understanding in disease etiology and experimental treatments whilst remaining in vivo. In this review, we present the current neuroimaging techniques used in AD research in both their human and animal applications, and discuss how this fits in to the overall goal of understanding AD.
Indexed as
Identifiers
23133824PMC3477739What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.